Literature DB >> 10673331

PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter.

N Braverman1, G Steel, P Lin, A Moser, H Moser, D Valle.   

Abstract

We recently reported cloning a cDNA encoding Pex7p, the peroxisomal PTS2 receptor. PEX7 mutations cause the peroxisome biogenesis disorder (PBD) rhizomelic chondrodysplasia punctata (RCDP). In a survey of 44 RCDP probands, we found that one PEX7 allele, L292ter, accounted for 50% of mutant PEX7 genes. Here we report the characterization of the PEX7 structural gene, which spans 102 kb on chromosome 6q21-q22.2 and contains at least 10 exons. In addition to the predominant full-length transcript, we identified eight smaller PEX7 transcripts generated by alternative exon splicing in several tissues. However, none of these splice forms was able to restore PTS2 protein import into peroxisomes when expressed in RCDP fibroblasts nor did they inhibit PTS2 protein import when expressed in normal fibroblasts. To determine whether the high frequency of the L292ter allele is due to a founder effect, we identified five polymorphic markers (four diallelic markers and one CA repeat) spanning the PEX7 gene. We show that all 12 L292ter homozygotes in our patient sample have an identical haplotype at these five sites, consistent with the hypothesis that the L292ter mutation arose once on an ancestral chromosome in the Caucasian population. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673331     DOI: 10.1006/geno.1999.6080

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

Review 1.  Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders.

Authors:  Y Suzuki; N Shimozawa; A Imamura; S Fukuda; Z Zhang; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

2.  Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds.

Authors:  Rui Zhang; Li Chen; Sarn Jiralerspong; Ann Snowden; Steven Steinberg; Nancy Braverman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

3.  Rhizomelic chondrodysplasia punctata type 1: report of mutations in 3 children from India.

Authors:  S R Phadke; N Gupta; K M Girisha; M Kabra; M Maeda; E Vidal; A Moser; S Steinberg; R D Puri; I C Verma; N Braverman
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

4.  Readthrough strategies for therapeutic suppression of nonsense mutations in inherited metabolic disease.

Authors:  B Pérez; P Rodríguez-Pombo; M Ugarte; L R Desviat
Journal:  Mol Syndromol       Date:  2012-10-02

5.  Colonic perforation in the first few hours of life associated with rhizomelic chondrodysplasia punctata.

Authors:  Timothy Fairbanks; Sherif Emil
Journal:  Pediatr Surg Int       Date:  2005-10-13       Impact factor: 1.827

6.  Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1.

Authors:  Alison M Motley; Pedro Brites; Lisya Gerez; Eveline Hogenhout; Janet Haasjes; Rob Benne; Henk F Tabak; Ronald J A Wanders; Hans R Waterham
Journal:  Am J Hum Genet       Date:  2002-01-07       Impact factor: 11.025

7.  Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations.

Authors:  Patricia K Dranchak; Erminia Di Pietro; Ann Snowden; Nathan Oesch; Nancy E Braverman; Steven J Steinberg; Joseph G Hacia
Journal:  J Cell Biochem       Date:  2011-05       Impact factor: 4.429

8.  Identification of PEX7 as the second gene involved in Refsum disease.

Authors:  Daan M van den Brink; Pedro Brites; Janet Haasjes; Anthony S Wierzbicki; John Mitchell; Michelle Lambert-Hamill; Jacqueline de Belleroche; Gerbert A Jansen; Hans R Waterham; Ronald J A Wanders
Journal:  Am J Hum Genet       Date:  2003-01-09       Impact factor: 11.025

9.  Human and great ape red blood cells differ in plasmalogen levels and composition.

Authors:  Ann B Moser; Steven J Steinberg; Paul A Watkins; Hugo W Moser; Krishna Ramaswamy; Kimberly D Siegmund; D Rick Lee; John J Ely; Oliver A Ryder; Joseph G Hacia
Journal:  Lipids Health Dis       Date:  2011-06-17       Impact factor: 3.876

10.  Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata.

Authors:  Tarik Luisman; Tara Smith; Shawn Ritchie; Karen E Malone
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.